
Adlai Nortye Investor Relations Material
Latest events

Corporate Presentation
30 May, 2025

Q4 2024
30 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Adlai Nortye Ltd
Access all reports
Adlai Nortye Ltd. is a global clinical-stage biopharmaceutical company primarily engaged in developing innovative immuno-oncology medicines. The company's mission is to improve patient lives by discovering and developing differentiated innovative treatments for cancer. It has a strategic focus on oncology, with research and development and global clinical operation centers located in the United States and China. The company is headquartered in North Brunswick, New Jersey, and its shares are listed on the Nasdaq.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ANL
Country
🇺🇸 United States